These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8738813)

  • 21. Effects of uremia and dialysis on brain electrophysiology after recombinant erythropoietin treatment.
    Di Paolo B; Di Liberato L; Fiederling B; Catucci G; Bucciarelli S; Paolantonio L; Albertazzi A
    ASAIO J; 1992; 38(3):M477-80. PubMed ID: 1457906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats.
    Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole blood superoxide anion generation and efficiency of some erythrocyte antioxidant systems during recombinant human erythropoietin therapy of uremic anemia.
    Luciak M; Pawlicki L; Kedziora J; Trznadel K; Błaszczyk J; Buczyński A
    Free Radic Biol Med; 1991; 10(6):397-401. PubMed ID: 1654288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients.
    Duff DR; Golper TA; Sloan RS; Brier ME; Aronoff GR
    Am J Kidney Dis; 1991 Jul; 18(1):60-4. PubMed ID: 2063856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin content is increased in the human erythroleukemia K562 cell line by a 56.2-kD peptide from uremic plasma.
    Fontanellas A; Navarro-Ordoñez S; Morán-Jiménez MJ; Guolo M; Franco C; García-Bravo M; Pataro L; Batlle A; de Salamanca RE
    Am J Nephrol; 2004; 24(2):230-4. PubMed ID: 15024177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced aminolevulinate dehydrase activity in rats with functional renal failure induced by cyclosporin A.
    Fontanellas A; Herrero JA; Enríquez de Salamanca R
    Exp Nephrol; 1997; 5(4):323-9. PubMed ID: 9259187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uremia enhances the blood pressure response to erythropoietin.
    Lacasse-M S; Kingma I; Larivière R; Grose JH; Lebel M
    Clin Exp Hypertens; 1997 May; 19(4):389-401. PubMed ID: 9140703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis].
    Ji SM; Li LS; Ji DX
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of middle molecules on the anemia of uremic patients.
    Leber HW; Spiegelhalter R; Ulm A; Goubeaud G; Rawer P
    Artif Organs; 1978 Nov; 2(4):378-81. PubMed ID: 743010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin.
    Brunati C; Cappellini MD; De Feo T; Guastoni C; Ballerini L; Busnach G; Civati G; Fiorelli G; Minetti L
    Am J Nephrol; 1992; 12(1-2):9-13. PubMed ID: 1415372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
    Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
    Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human erythropoietin improves enzyme activity in erythrocytes of predialysis uremics.
    Pietrzak I; Baczyk K; Kubiak W
    Miner Electrolyte Metab; 1996; 22(1-3):102-5. PubMed ID: 8676797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin.
    Schaefer RM; Kokot F; Kuerner B; Zech M; Heidland A
    Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
    Wiecek A; Kokot F; Grzeszczak W; Klin M
    Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE; Ou CN; Ellefson RD
    Clin Chem; 1980 Jul; 26(8):1182-5. PubMed ID: 7389090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.